Article

Aglycosylated immunoglobulin G1 variants productively engage activating Fc receptors. Proc. Natl. Acad. Sci. USA. 105: 20167-20172

Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 01/2009; 105(51):20167-72. DOI: 10.1073/pnas.0809257105
Source: PubMed

ABSTRACT

Immunoglobulin G plays a vital role in adaptive immunity and antibody-based therapy through engagement of its Fc region by the Fc gamma receptors (Fc gammaRs) on immune cells. In addition to specific protein-protein contacts, N-linked glycosylation of the IgG Fc has been thought to be essential for the recognition of Fc by Fc gammaR. This requirement for the N-linked glycan has limited biomanufacture of therapeutic antibodies by restricting it to mammalian expression systems. We report here aglycosylated Fc domain variants that maintain engagement to Fc gammaRs, both in vitro and in vivo, demonstrating that Fc glycosylation is not strictly required for the activation of immune cells by IgG. These variants provide insight into how the N-linked glycan is used biologically in the recognition of Fc by Fc gammaRs, as well as represent a step toward the production in alternative expression systems of antibody-based therapeutics capable of eliciting immune effector functions.

Download full-text

Full-text

Available from: Bruce Tidor
    • "In addition, HuMAb with the Fc region mutation, D23-1G7C2-IgG1-N297A, showed the least ADE activity (Fig. 2), without losing neutralizing activity (Fig. 1B). A single mutation at N297 residue of IgG has been shown to impair the binding to FcgR (Arnold et al., 2007;Sazinsky et al., 2008;Lux et al., 2013). D23-1G7C2-IgG1-N297A is an ideal therapeutic antibody ; however, D23-1G7C2-IgG1-N297A partially lost its protective activity (Fig. 3A). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Antibody-dependent enhancement (ADE) of dengue virus (DENV) infectivity is thought to play a crucial role in severe dengue disease. It occurs when pre-existing sub-neutralizing anti-DENV antibody (Ab) produced from a primary infection encounters a DENV serotype different from that of the initial infection and forms immune complexes, which enable the efficient infection of Fcγ receptor-bearing cells. However, the exact role played by Abs during a secondary infection of patients remains unknown. We previously obtained a broadly cross-reactive neutralizing IgG1 human monoclonal anti-DENV envelope (E) Ab (HuMAb) D23-1G7C2-IgG1 from a DENV-infected patient; however, D23-1G7C2-IgG1 had ADE activity. With the aim of being able to reduce the ADE activity, we exchanged the Fc region of D23-1G7C2 to generate Abs bearing each of the three other IgG subclasses (IgG2-4). In addition, N297A, a mutation known to reduce the affinity of the IgG1 Fc region for Fcγ receptors, was introduced into D23-1G7C2-IgG1. Swapping D23-1G7C2-IgG1 to IgG2 or IgG4 subclasses reduced ADE activity in FcγRI and FcγRII-bearing THP-1 cells. By contrast, in FcγRII-bearing K562 cells, the change to IgG2 increased ADE activity. Introducing the N297A mutation into D23-1G7C2-IgG1 resulted in a marked reduction in ADE activity in both cell types. Compared to D23-1G7C2-IgG1, D23-1G7C2-IgG1-N297A was less protective in IFN-α/β/γ receptor knockout mice infected with a lethal dose of recombinant chimeric DENV, carrying prME of DENV-2 in Japanese encephalitis virus (80% vs. 40% survival, respectively). These observations provide valuable information regarding the use of recombinant Abs as therapeutics.
    No preview · Article · Nov 2015 · Antiviral research
  • Source
    • "In this study, we evaluate the contribution of Fc N-glycosylation to Fc structure and FcgRIIIa affinity to determine how the Fc N-glycan contributes to Fc activity and, in so doing, define the mechanism behind a previously unknown role for N-glycans in biology. We utilized two well-described Fc variants that are reported to show no measurable affinity for FcgRIIIa: (glycosyl) Fc D265A (Baudino et al., 2008; Bournazos et al., 2014; Clynes et al., 2000; Lund et al., 1995, 1996) and (aglycosyl) Fc T299A (Lazar et al., 2009; Sazinsky et al., 2008; Subedi et al., 2014). Here, we report the identification of IgG1 Fc features that are stabilized by N-glycosylation, and in the stabilized state contribute to FcgRIIIa binding. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Asparagine(N)297-linked glycosylation of immunoglobulin G (IgG) Fc is required for binding to FcγRIIa, IIb, and IIIa, although it is unclear how it contributes. We found the quaternary structure of glycosylated Fc was indistinguishable from aglycosylated Fc, indicating that N-glycosylation does not maintain relative Fc Cγ2/Cγ3 domain orientation. However, the conformation of the C'E loop, which contains N297, was significantly perturbed in the aglycosylated Fc variant. The conformation of the C'E loop as measured with a range of Fc variants shows a strong correlation with FcγRIIIa affinity. These results indicate that the primary role of the IgG1 Fc N-glycan is to stabilize the C'E loop through intramolecular interactions between carbohydrate and amino acid residues, and preorganize the FcγRIIIa interface for optimal binding affinity. The features that contribute to the capacity of the IgG1 Fc N-glycan to restrict protein conformation and tune binding affinity are conserved in other antibodies including IgG2-IgG4, IgD, IgE, and IgM. Copyright © 2015 Elsevier Ltd. All rights reserved.
    Full-text · Article · Sep 2015 · Structure
    • "Site - specific N - glycans can affect the function of glycoproteins , e . g . immunoglobulins ( Niwa et al . 2004 ; Scallon et al . 2007 ; Sazinsky et al . 2008 ; Ferrara et al . 2011 ) , but for most glycoproteins , this has not been addresses experimentally . It is evident that the quantitative analysis of site - specific glycans will be essential for future research in this direction . The MS - based , quantitative glycoproteomics method presented in this report will become a valuable tool t"
    [Show abstract] [Hide abstract]
    ABSTRACT: The hallmark of N-linked protein glycosylation is the generation of diverse glycan structures in the secretory pathway. Dynamic, non-template-driven processes of N-glycan remodeling in the endoplasmic reticulum and the Golgi provide the cellular setting for structural diversity. We applied newly developed mass spectrometry-based analytics to quantify site-specific N-glycan remodeling of the model protein Pdi1p expressed in insect cells. Molecular dynamics simulation, mutational analysis, kinetic studies of in vitro processing events and glycan flux analysis supported the defining role of the protein in N-glycan processing.
    No preview · Article · Aug 2015 · Glycobiology
Show more